I published “Managing Acute and Chronic Pain” on @Medium https://ift.tt/2TVbVlE
Friday, May 29, 2020
Saturday, May 23, 2020
Published: Making the Most of an Auto Show Visit
I published “Making the Most of an Auto Show Visit” on @Medium https://ift.tt/2WX4BYD
How Virtual Test Drives Can Lead to Real-World Sales
An unlikely tool some automakers are using in their efforts to increase sales is video game product marketing. It’s not a new concept, with car product placement dating back to 1995, but it’s one that has gained many serious adopters.
The latest driving simulation games offer realistic physics and a relatively accurate representation of some key car features, such as acceleration and cornering. The automotive giant Ford cited video games as an integral part of its marketing plan, and attributed it to increasing its brand rating by 28 percent.
Hypercar manufacturer Pagani took it one step further. Pagani revealed one of its newest models, the Huayra Roadster BC, in a video game before the real-world model even appeared at car shows.
Monday, May 11, 2020
Potential Alternatives to Opioids in Pain Relief
Manny Bojorquez is an entrepreneur and co-founder of peaCURE, a company that markets products formulated on the basis of palmitoylethanolamide. Palmitoylethanolamide’s role as a potential replacement for opioids is of particular interest to Manny Bojorquez, as is how the compound can be used to help ameliorate the effects of the opioid epidemic.
Besides palmitoylethanolamide, there other pharmacological solutions that are being developed to replace opioids. This category of medications is referred to as bisphosphonates. Typically used to prevent bone loss, bisphosphonates have also shown success in the treatment of complex regional pain syndrome which is a neurological condition causing intense chronic pain.
Gene therapy is also being studied, especially the use of monoclonal antibodies. Research indicates that nerve growth factor plays a big role in the generation of a variety of pain states so considerable resources are being used to develop anti-NGF drugs. As anti-NGF agents, monoclonal antibodies can produce a significant reduction in pain for patients with osteoarthritis, and other chronic pains such as peripheral neuropathy.
Friday, May 8, 2020
Published: Why Bioavailability Makes a Big Difference in Palmitoylethanolamide
I published “Why Bioavailability Makes a Big Difference in Palmitoylethanolamide” on @Medium https://ift.tt/2Le54z2
Subscribe to:
Comments (Atom)